Angiogenic signaling pathways and anti-angiogenic therapy for cancer
ZL Liu, HH Chen, LL Zheng, LP Sun… - Signal transduction and …, 2023 - nature.com
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
W Li, JB Liu, LK Hou, F Yu, J Zhang, W Wu, XM Tang… - Molecular cancer, 2022 - Springer
Primary lung cancer is one of the most common malignant tumors in China. Approximately
60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is …
60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is …
Challenges for assessing replicability in preclinical cancer biology
TM Errington, A Denis, N Perfito, E Iorns, BA Nosek - Elife, 2021 - elifesciences.org
We conducted the Reproducibility Project: Cancer Biology to investigate the replicability of
preclinical research in cancer biology. The initial aim of the project was to repeat 193 …
preclinical research in cancer biology. The initial aim of the project was to repeat 193 …
Cancer stem cells as key drivers of tumour progression
AZ Ayob, TS Ramasamy - Journal of biomedical science, 2018 - Springer
Abstract Background Cancer stem cells (CSCs) are subpopulations of cancer cells sharing
similar characteristics as normal stem or progenitor cells such as self-renewal ability and …
similar characteristics as normal stem or progenitor cells such as self-renewal ability and …
Prognostic and predictive biomarkers in breast cancer: Past, present and future
Following a diagnosis of breast cancer, the most immediate challenges in patient
management are the determination of prognosis and identification of the most appropriate …
management are the determination of prognosis and identification of the most appropriate …
Exosome and exosomal microRNA: trafficking, sorting, and function
J Zhang, S Li, L Li, M Li, C Guo, J Yao… - Genomics, Proteomics …, 2015 - academic.oup.com
Abstract Exosomes are 40–100 nm nano-sized vesicles that are released from many cell
types into the extracellular space. Such vesicles are widely distributed in various body fluids …
types into the extracellular space. Such vesicles are widely distributed in various body fluids …
Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
C Gong, J Tian, Z Wang, Y Gao, X Wu, X Ding… - Journal of …, 2019 - Springer
Exosomes (Exo) hold great promise as endogenous nanocarriers that can deliver biological
information between cells. However, Exo are limited in terms of their abilities to target …
information between cells. However, Exo are limited in terms of their abilities to target …
MicroRNAs in cancer: biomarkers, functions and therapy
The emergence of microRNAs has been one of the defining developments in cancer biology
over the past decade, and the explosion of knowledge in this area has brought forward new …
over the past decade, and the explosion of knowledge in this area has brought forward new …
Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement
Upon exposure to stress, tRNAs are enzymatically cleaved, yielding distinct classes of tRNA-
derived fragments (tRFs). We identify a novel class of tRFs derived from tRNA Glu, tRNA …
derived fragments (tRFs). We identify a novel class of tRFs derived from tRNA Glu, tRNA …
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
The first cancer-targeted microRNA (miRNA) drug—MRX34, a liposome-based miR-34
mimic—entered Phase I clinical trials in patients with advanced hepatocellular carcinoma in …
mimic—entered Phase I clinical trials in patients with advanced hepatocellular carcinoma in …